There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.
Justin (JC) Liauw, PharmD, BCOP
Advertisement
Articles by Justin (JC) Liauw, PharmD, BCOP
New potential medications may continue to expand the role of targeted agents.
Advertisement
Latest Updated Articles
Overview of PARP Inhibitors in the Treatment of Ovarian CancerOctober 11th 2021
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2
2
Heal or Harm: Body Protective Compound-157 in the Gray Zone
3
COVID-19 Boosters May Offer Head Start Against Future Animal Coronaviruses, But Immune "Imprinting" Complicates the Picture
4
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
5